[Proceedings: Clinical evaluation of a new protein anabolic steroid, 2 alpha-3 alpha-epithio-5 alpha-androstan-17 beta-yl, 1, -methoxycyxlopentyl ether (10364-S)].
D045930:Anabolic Agents / Q000627:therapeutic use*; D000731:Androstanes / Q000627:therapeutic use*; D000740:Anemia / Q000188:drug therapy; D004341:Drug Evaluation; D004987:Ethers / Q000627:therapeutic use; D006801:Humans; D008297:Male; D013440:Sulfides / Q000627:therapeutic use
D045930:Anabolic Agents; D000731:Androstanes; D004987:Ethers; D013440:Sulfides